Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 27% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2686.38 | 1445 / 1445 | 100% | 9.90 | 183 / 183 |
prostate | 100% | 2721.70 | 245 / 245 | 100% | 9.51 | 502 / 502 |
skin | 100% | 3005.60 | 1809 / 1809 | 100% | 12.05 | 472 / 472 |
stomach | 100% | 2168.68 | 359 / 359 | 100% | 10.46 | 286 / 286 |
brain | 100% | 3375.51 | 2641 / 2642 | 100% | 11.59 | 705 / 705 |
lung | 100% | 2461.58 | 578 / 578 | 100% | 9.85 | 1154 / 1155 |
breast | 100% | 2589.81 | 459 / 459 | 100% | 10.45 | 1117 / 1118 |
intestine | 100% | 3874.08 | 966 / 966 | 100% | 10.16 | 526 / 527 |
bladder | 100% | 2333.38 | 21 / 21 | 100% | 8.95 | 503 / 504 |
thymus | 100% | 2959.14 | 653 / 653 | 100% | 9.59 | 603 / 605 |
kidney | 100% | 2867.01 | 89 / 89 | 100% | 9.45 | 898 / 901 |
uterus | 100% | 2544.87 | 170 / 170 | 100% | 8.69 | 457 / 459 |
pancreas | 100% | 1680.53 | 328 / 328 | 99% | 9.42 | 177 / 178 |
ovary | 100% | 2119.55 | 180 / 180 | 99% | 7.55 | 425 / 430 |
liver | 100% | 2189.44 | 226 / 226 | 98% | 7.06 | 398 / 406 |
adrenal gland | 100% | 3115.38 | 258 / 258 | 97% | 7.66 | 223 / 230 |
adipose | 100% | 2440.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 10.86 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.24 | 29 / 29 |
muscle | 100% | 1533.70 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2933.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.47 | 1 / 1 |
blood vessel | 100% | 2380.04 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1466.34 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 2028.39 | 840 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016558 | Biological process | protein import into peroxisome matrix |
GO_0045046 | Biological process | protein import into peroxisome membrane |
GO_0022615 | Biological process | protein to membrane docking |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0043495 | Molecular function | protein-membrane adaptor activity |
GO_0051117 | Molecular function | ATPase binding |
Gene name | PEX26 |
Protein name | Peroxisomal biogenesis factor 26 isoform 2 Peroxisome assembly protein 26 (Peroxin-26) Peroxisomal biogenesis factor 26 isoform 1 (Peroxisome biogenesis factor 26, isoform CRA_a) |
Synonyms | hCG_1817601 |
Description | FUNCTION: Peroxisomal docking factor that anchors PEX1 and PEX6 to peroxisome membranes . PEX26 is therefore required for the formation of the PEX1-PEX6 AAA ATPase complex, a complex that mediates the extraction of the PEX5 receptor from peroxisomal membrane . . |
Accessions | ENST00000428061.2 [Q7Z412-2] Q7Z412 A0A0S2Z5M7 ENST00000399744.8 [Q7Z412-1] ENST00000329627.11 [Q7Z412-1] A0A024R100 |